These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. Arnaldi G, Tirabassi G, Papa R, Furlani G, Trementino L, Cardinaletti M, Faloia E, Boscaro M. Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661 [Abstract] [Full Text] [Related]
28. [The value of corticotropin-releasing hormone (CRH) test for differential diagnosis of Cushing's syndrome]. Penezić Z, Zarković M, Vujović S, Ivović M, Beleslin B, Ciric J, Drezgić M. Srp Arh Celok Lek; 2007 Jun; 135(1-2):31-7. PubMed ID: 17503565 [Abstract] [Full Text] [Related]
29. An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings. Blunt SB, Sandler LM, Burrin JM, Joplin GF. Q J Med; 1990 Nov; 77(283):1113-33. PubMed ID: 2177207 [Abstract] [Full Text] [Related]
30. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH. Ann Intern Med; 1986 Feb; 104(2):180-6. PubMed ID: 3004275 [Abstract] [Full Text] [Related]
31. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndrome. Detomas M, Ritzel K, Nasi-Kordhishti I, Wolfsberger S, Quinkler M, Losa M, Tröger V, Kroiss M, Fassnacht M, Vila G, Honegger JB, Reincke M, Deutschbein T. Front Endocrinol (Lausanne); 2022 Feb; 13():955945. PubMed ID: 36277711 [Abstract] [Full Text] [Related]
32. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome. van den Bogaert DP, de Herder WW, de Jong FH, Biemond P, van der Lely AJ, Lamberts SW. Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990 [Abstract] [Full Text] [Related]
33. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Malchoff CD, Orth DN, Abboud C, Carney JA, Pairolero PC, Carey RM. Am J Med; 1988 Apr; 84(4):760-4. PubMed ID: 2840823 [Abstract] [Full Text] [Related]
38. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. Tsagarakis S, Tsigos C, Vasiliou V, Tsiotra P, Kaskarelis J, Sotiropoulou C, Raptis SA, Thalassinos N. J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296 [Abstract] [Full Text] [Related]
39. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. Kaltsas GA, Giannulis MG, Newell-Price JD, Dacie JE, Thakkar C, Afshar F, Monson JP, Grossman AB, Besser GM, Trainer PJ. J Clin Endocrinol Metab; 1999 Feb; 84(2):487-92. PubMed ID: 10022405 [Abstract] [Full Text] [Related]